Cargando…

Treatment delay and tumor size in patients with oral cancer during the first year of the COVID‐19 pandemic

BACKGROUND: We set out to investigate how the ongoing coronavirus pandemic affected the size of tumors and the duration of treatment delay in patients with surgically treated oral squamous cell carcinoma. METHODS: Patients with surgically treated oral cavity squamous cell carcinoma were assessed ret...

Descripción completa

Detalles Bibliográficos
Autores principales: Metzger, Karl, Mrosek, Jan, Zittel, Sven, Pilz, Maximilian, Held, Thomas, Adeberg, Sebastian, Ristow, Oliver, Hoffmann, Jürgen, Engel, Michael, Freudlsperger, Christian, Moratin, Julius
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8652728/
https://www.ncbi.nlm.nih.gov/pubmed/34494330
http://dx.doi.org/10.1002/hed.26858
_version_ 1784611611027177472
author Metzger, Karl
Mrosek, Jan
Zittel, Sven
Pilz, Maximilian
Held, Thomas
Adeberg, Sebastian
Ristow, Oliver
Hoffmann, Jürgen
Engel, Michael
Freudlsperger, Christian
Moratin, Julius
author_facet Metzger, Karl
Mrosek, Jan
Zittel, Sven
Pilz, Maximilian
Held, Thomas
Adeberg, Sebastian
Ristow, Oliver
Hoffmann, Jürgen
Engel, Michael
Freudlsperger, Christian
Moratin, Julius
author_sort Metzger, Karl
collection PubMed
description BACKGROUND: We set out to investigate how the ongoing coronavirus pandemic affected the size of tumors and the duration of treatment delay in patients with surgically treated oral squamous cell carcinoma. METHODS: Patients with surgically treated oral cavity squamous cell carcinoma were assessed retrospectively and divided into two groups depending on when they had first presented at our clinic. Patients presenting from 2010 to 2019, that is, before COVID‐19 onset (n = 566) were compared to patients presenting in 2020 (n = 58). RESULTS: A total of 624 patients were included. Treatment delay was significantly longer in 2020 (median = 45 days) versus 2010–2019 (median = 35 days) (p = 0.004). We observed a higher pathological T classification in 2020 (p = 0.046), whereas pathological N classification was unchanged between groups (p = 0.843). CONCLUSIONS: While extraordinary efforts continue to be made in the context of the pandemic, it is imperative that this does not lead to significant disadvantages for many people with oral cancer.
format Online
Article
Text
id pubmed-8652728
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley & Sons, Inc.
record_format MEDLINE/PubMed
spelling pubmed-86527282021-12-08 Treatment delay and tumor size in patients with oral cancer during the first year of the COVID‐19 pandemic Metzger, Karl Mrosek, Jan Zittel, Sven Pilz, Maximilian Held, Thomas Adeberg, Sebastian Ristow, Oliver Hoffmann, Jürgen Engel, Michael Freudlsperger, Christian Moratin, Julius Head Neck Original Articles BACKGROUND: We set out to investigate how the ongoing coronavirus pandemic affected the size of tumors and the duration of treatment delay in patients with surgically treated oral squamous cell carcinoma. METHODS: Patients with surgically treated oral cavity squamous cell carcinoma were assessed retrospectively and divided into two groups depending on when they had first presented at our clinic. Patients presenting from 2010 to 2019, that is, before COVID‐19 onset (n = 566) were compared to patients presenting in 2020 (n = 58). RESULTS: A total of 624 patients were included. Treatment delay was significantly longer in 2020 (median = 45 days) versus 2010–2019 (median = 35 days) (p = 0.004). We observed a higher pathological T classification in 2020 (p = 0.046), whereas pathological N classification was unchanged between groups (p = 0.843). CONCLUSIONS: While extraordinary efforts continue to be made in the context of the pandemic, it is imperative that this does not lead to significant disadvantages for many people with oral cancer. John Wiley & Sons, Inc. 2021-09-08 2021-11 /pmc/articles/PMC8652728/ /pubmed/34494330 http://dx.doi.org/10.1002/hed.26858 Text en © 2021 The Authors. Head & Neck published by Wiley Periodicals LLC. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Metzger, Karl
Mrosek, Jan
Zittel, Sven
Pilz, Maximilian
Held, Thomas
Adeberg, Sebastian
Ristow, Oliver
Hoffmann, Jürgen
Engel, Michael
Freudlsperger, Christian
Moratin, Julius
Treatment delay and tumor size in patients with oral cancer during the first year of the COVID‐19 pandemic
title Treatment delay and tumor size in patients with oral cancer during the first year of the COVID‐19 pandemic
title_full Treatment delay and tumor size in patients with oral cancer during the first year of the COVID‐19 pandemic
title_fullStr Treatment delay and tumor size in patients with oral cancer during the first year of the COVID‐19 pandemic
title_full_unstemmed Treatment delay and tumor size in patients with oral cancer during the first year of the COVID‐19 pandemic
title_short Treatment delay and tumor size in patients with oral cancer during the first year of the COVID‐19 pandemic
title_sort treatment delay and tumor size in patients with oral cancer during the first year of the covid‐19 pandemic
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8652728/
https://www.ncbi.nlm.nih.gov/pubmed/34494330
http://dx.doi.org/10.1002/hed.26858
work_keys_str_mv AT metzgerkarl treatmentdelayandtumorsizeinpatientswithoralcancerduringthefirstyearofthecovid19pandemic
AT mrosekjan treatmentdelayandtumorsizeinpatientswithoralcancerduringthefirstyearofthecovid19pandemic
AT zittelsven treatmentdelayandtumorsizeinpatientswithoralcancerduringthefirstyearofthecovid19pandemic
AT pilzmaximilian treatmentdelayandtumorsizeinpatientswithoralcancerduringthefirstyearofthecovid19pandemic
AT heldthomas treatmentdelayandtumorsizeinpatientswithoralcancerduringthefirstyearofthecovid19pandemic
AT adebergsebastian treatmentdelayandtumorsizeinpatientswithoralcancerduringthefirstyearofthecovid19pandemic
AT ristowoliver treatmentdelayandtumorsizeinpatientswithoralcancerduringthefirstyearofthecovid19pandemic
AT hoffmannjurgen treatmentdelayandtumorsizeinpatientswithoralcancerduringthefirstyearofthecovid19pandemic
AT engelmichael treatmentdelayandtumorsizeinpatientswithoralcancerduringthefirstyearofthecovid19pandemic
AT freudlspergerchristian treatmentdelayandtumorsizeinpatientswithoralcancerduringthefirstyearofthecovid19pandemic
AT moratinjulius treatmentdelayandtumorsizeinpatientswithoralcancerduringthefirstyearofthecovid19pandemic